Floatz logo

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-

Essential Tremor

GE HealthcareSmall moleculePhase 3Active
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Essential Tremor cohort.

Asset / SponsorPhaseRating
FALLYPRIDE
GE Healthcare
Phase 3BB
IOFLUPANE
GE Healthcare
Phase 3BB
DEXDOMITOR
Vanderbilt University
Phase 2/3B
TACROLIMUS
University of Oxford
N/AD
PROPOFOL
University of Texas Southwestern Medical Center
D
APOMORPHINUM
University of Texas Southwestern Medical Center
N/AD

Same molecule, other indications

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:

Alzheimer DementiaDormant
BB
Indicative ·
66 / 100
View asset →
Breast CancerDormant
B
Indicative ·
58 / 100
View asset →
Stage IIB Breast CancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →